Alberto Zaniboni
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 263 publications
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026
Fostering human dignity during chemotherapy: An explorative study on Dignity Therapy in advanced gastric and pancreatic cancer.
Journal: Palliative & supportive care
Published: August 11, 2026
Interstitial lung disease in patients treated with antibody-drug conjugates: a review.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 24, 2026
Post-diagnostic ultra-processed food exposure in gastrointestinal cancers: scoping review with narrative synthesis and clinical implications.
Journal: Frontiers in nutrition
Published: May 18, 2026
Psychological Stress and Cancer Risk and Outcome: An Umbrella Review With Quantitative Synthesis.
Journal: Asia-Pacific journal of clinical oncology
Published: May 06, 2026
Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes.
Journal: Cancer treatment reviews
Published: April 14, 2026
Comment on "Triplet chemotherapy combined with anti-EGFR treatment in RAS wild-type colorectal cancer: a network meta-analysis".
Journal: The oncologist
Published: April 01, 2026
Cancer-Related Cognitive Impairment in Breast Cancer: Current State of Knowledge, Mechanisms, Diagnosis, Prevention and Treatment.
Journal: Cancers
Published: March 25, 2026
Adjuvant Chemotherapy After Curative Intent Resection of Ampullary Cancer (ADAPTA): Study Protocol for a Pan-European Prospective Multicenter Double Single Arm Trial.
Journal: American journal of clinical oncology
Published: March 11, 2026
Ocular Toxicities of Anticancer Therapies in the Era of Precision Oncology: A Practical, Clinically Oriented Narrative Review.
Journal: Biomedicines
Published: February 10, 2026
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2026
Last Updated: 09/26/2026